The effects of cannabinoid receptor antagonists against neuroprotective effects of compound 4f in KA-treated mice. by Naoto Arimura (416442)

Subjects:

Representative image data in Fig 5. by Naoto Arimura (416442)

Subjects:

Pharmacokinetics and pharmacodynamics of compound 4f in mice. by Naoto Arimura (416442)

Subjects:

Effects of compound 4f on cognitive function in mice with KA-induced neurodegeneration. by Naoto Arimura (416442)

Subjects:

Top 20 Ingenuity Pathway Analysis (IPA) pathways of 3382 genes upregulated following KA treatment with a <i>P</i>-value of < 0.05. by Naoto Arimura (416442)

Subjects:

Effects of compound 4f on neuronal cell loss in mice with KA-induced neurodegeneration. by Naoto Arimura (416442)

Subjects:

Top 20 IPA pathways of 1131 genes downregulated by compound 4f among genes upregulated following KA treatment with a <i>P</i>-value of < 0.05. by Naoto Arimura (416442)

Subjects:

Top 20 IPA pathways of 234 genes upregulated by compound 4f among genes downregulated following KA treatment with a <i>P</i>-value of < 0.05. by Naoto Arimura (416442)

Subjects:

Immunohistochemistry using anti-Iba-1 and GFAP antibodies. by Naoto Arimura (416442)

Subjects:

Comparison of altered gene expression across groups of saline/vehicle-, KA/vehicle-, and KA/compound 4f-treated mice. by Naoto Arimura (416442)

Subjects:

Effects of compound 4f on the seizure-like response elicited by kainic acid (KA). by Naoto Arimura (416442)

Subjects:

Gene expression levels of <i>CB1R</i>, <i>CB2R</i>, and <i>MAGL</i> in KA-injected mice treated with compound 4f. by Naoto Arimura (416442)

Subjects:

Comparative analysis of macronutrient compositions between baseline and end of intervention (*p < 0.05, ^ns Non-significant results). by Duc Tran Quang (20564967)

Comparative analysis of caloric intake between baseline and end of intervention (*p < 0.05, ^ns Non-significant results). by Duc Tran Quang (20564967)

Results of RF regression model validation and significance of influencing factors (desert area change and spatiotemporal characteristics of ERI). by Mingyue Sun (4638535)

Significant repeated measurements sEMG outcomes. by María Benito-de-Pedro (22057468)

Subjects:

Significant single measurement sEMG outcomes. by María Benito-de-Pedro (22057468)

Subjects:

Modified version of the Caregiving Stress Model for Post Intensive Care Syndrome – Family impairments. by Cristobal Padilla-Fortunatti (21376807)

Subjects:

SPIRIT schedule: Timeline of recruitment and assessment. <i>t</i>₀: Daily screening; <i>t</i>₁: Between the 3^rd and 10^th day of ICU admi... by Cristobal Padilla-Fortunatti (21376807)

Subjects:

Questionnaire description. by Cristobal Padilla-Fortunatti (21376807)

Subjects: